UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000044230
Receipt number R000050448
Scientific Title Prognostic accuracy of shock index for severe postpartum hemorrhage in high-income country: Protocol for a systematic review and meta-analysis
Date of disclosure of the study information 2021/05/24
Last modified on 2022/11/03 10:01:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prognostic accuracy of shock index for severe postpartum hemorrhage in high-income country: Protocol for a systematic review and meta-analysis

Acronym

Prognostic accuracy of shock index for severe postpartum hemorrhage in high-income country: Protocol for a systematic review and meta-analysis

Scientific Title

Prognostic accuracy of shock index for severe postpartum hemorrhage in high-income country: Protocol for a systematic review and meta-analysis

Scientific Title:Acronym

Prognostic accuracy of shock index for severe postpartum hemorrhage in high-income country: Protocol for a systematic review and meta-analysis

Region

Japan


Condition

Condition

Postpartum hemorrhage (PPH)

Classification by specialty

Obstetrics and Gynecology Emergency medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this review is to conduct a systematic review and meta-analysis of relevant studies based on a rigorous methodology and to assess the prognostic value of shock index for prediction of severe PPH requiring higher-level care in high-income countries.

Basic objectives2

Others

Basic objectives -Others

Not applicable

Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

We will assess severe PPH required higher-level care as a primary outcome for a meta-analysis. It is defined as the need for use of blood products, interventional radiology, laparotomy (other than cesarean section), or admission to intensive care unit (ICU).

Key secondary outcomes

We will also assess a blood loss of 1000 ml or more within 24 hours after birth as a secondary outcome for a meta-analysis.


Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1 women in the peripartum period
2 studies in high-income countries defined by World Bank Country and Lending Groups
3 studies evaluating the incidence of severe PPH or the adverse events associated with PPH

Key exclusion criteria

studies reporting insufficient data for constructing a two by two table.
We will also exclude case reports and diagnostic case control studies.

Target sample size

0


Research contact person

Name of lead principal investigator

1st name Yuto
Middle name
Last name Makino

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Preventive Services

Zip code

6068501

Address

Yoshida-Honmachi, Sakyo-ku, Kyoto

TEL

075-753-2426

Email

yuuto.m78@gmail.com


Public contact

Name of contact person

1st name Yuto
Middle name
Last name Makino

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Preventive Services

Zip code

6068501

Address

Yoshida-Honmachi, Sakyo-ku, Kyoto

TEL

075-753-2426

Homepage URL


Email

yuuto.m78@gmail.com


Sponsor or person

Institute

Department of Preventive Services,
Kyoto University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

not applicable

Address

not applicable

Tel

not applicable

Email

not applicable


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 05 Month 24 Day


Related information

URL releasing protocol

https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15292

Publication of results

Published


Result

URL related to results and publications

https://obgyn.onlinelibrary.wiley.com/doi/10.1111/jog.15292

Number of participants that the trial has enrolled

9

Results

Nine studies were included after the eligibility assessment. All studies were considered to either have a high risk of bias or high applicability concerns. The sensitivity of the four studies that defined severe PPH as PPH requiring blood transfusion ranged from 0.51 to 0.80, whereas their specificity ranged from 0.33 to 0.92.

Results date posted

2022 Year 11 Month 03 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

NA

Participant flow

NA

Adverse events

NA

Outcome measures

NA

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 05 Month 17 Day

Date of IRB

2021 Year 05 Month 17 Day

Anticipated trial start date

2021 Year 05 Month 17 Day

Last follow-up date

2021 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2021 Year 10 Month 10 Day


Other

Other related information

Protocol registered in medRxiv (https://www.medrxiv.org/)


Management information

Registered date

2021 Year 05 Month 17 Day

Last modified on

2022 Year 11 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050448


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name